{
    "eid": "2-s2.0-85133443843",
    "title": "Risperidone plasma concentrations are associated with hyperprolactinemia in autism spectrum disorder children: The impact of CYP2D6 polymorphisms",
    "cover-date": "2022-08-01",
    "subject-areas": [
        {
            "@_fa": "true",
            "$": "Developmental and Educational Psychology",
            "@code": "3204",
            "@abbrev": "PSYC"
        },
        {
            "@_fa": "true",
            "$": "Clinical Psychology",
            "@code": "3203",
            "@abbrev": "PSYC"
        },
        {
            "@_fa": "true",
            "$": "Psychiatry and Mental Health",
            "@code": "2738",
            "@abbrev": "MEDI"
        }
    ],
    "keywords": [
        "Allele-specific primer extension",
        "ASD",
        "Chemiluminescence immunoassay",
        "CYP2D6 genotyping",
        "Luminex xTAG",
        "Prolactin",
        "Risperidone"
    ],
    "authors": [
        "Monpat Chamnanphon",
        "Natchaya Vanwong",
        "Santirhat Prommas",
        "Napatrupron Koomdee",
        "Rattanaporn Sukprasong",
        "Jiratha Rachanakul",
        "Nutthan Nuntharadthanaphong",
        "Yaowaluck Hongkaew",
        "Shobana John",
        "Nattawat Ngamsamut",
        "Nopphadol Nuntamool",
        "Penkhae Limsila",
        "Chonlaphat Sukasem"
    ],
    "citedby-count": 0,
    "ref-count": 28,
    "ref-list": [
        "CYP2D6 and DRD2 genes differentially impact pharmacodynamic sensitivity and time course of prolactin response to perphenazine",
        "The effect of CYP2D6 variation on antipsychotic-induced hyperprolactinaemia: A systematic review and meta-analysis",
        "Comparative pharmacology of risperidone and paliperidone",
        "Pharmacogenetics of risperidone therapy in autism: association analysis of eight candidate genes with drug efficacy and adverse drug reactions",
        "Reference ranges for serum concentrations of lutropin (LH), follitropin (FSH), estradiol (E2), prolactin, progesterone, sex hormone-binding globulin (SHBG), dehydroepiandrosterone sulfate (DHEAS), cortisol and ferritin in neonates, children and young adults",
        "Metabolism of risperidone to 9-hydroxyrisperidone by human cytochromes P450 2D6 and 3A4",
        "Hyperprolactinemia and CYP2D6, DRD2 and HTR2C genes polymorphism in patients with schizophrenia",
        "Effect of clozapine and risperidone on 5-HT2 and D2-dopamine receptor binding in the post-mortem human brain. An autoradiographic study",
        "Clinical pharmacogenetics implementation consortium (CPIC) guideline for CYP2D6 and CYP2C19 genotypes and dosing of selective serotonin reuptake inhibitors",
        "UGT1A1 polymorphisms associated with prolactin response in risperidone-treated children and adolescents with autism spectrum disorder",
        "Hyperprolactinemia in Thai children and adolescents with autism spectrum disorder treated with risperidone",
        "Resolving discordant CYP2D6 genotyping results in Thai subjects: Platform limitations and novel haplotypes",
        "Pharmacology of risperidone (R 64 766), a new antipsychotic with serotonin-S2 and dopamine-D2 antagonistic properties",
        "Cytochrome P450 2D catalyze steroid 21-hydroxylation in the brain",
        "Predominant role of the 9-hydroxy metabolite of risperidone in elevating blood prolactin levels",
        "Effect of CYP2D6 polymorphisms on plasma concentration and therapeutic effect of risperidone",
        "9-Hydroxyrisperidone-induced hyperprolactinaemia in Thai children and adolescents with autism spectrum disorder",
        "CYP2D6 genotype in relation to perphenazine concentration and pituitary pharmacodynamic tissue sensitivity in Asians: CYP2D6-serotonin-dopamine crosstalk revisited",
        "The effect of the Taq1A variant in the dopamine D\u2082 receptor gene and common CYP2D6 alleles on prolactin levels in risperidone-treated boys",
        "Prolactin levels: Sex differences in the effects of risperidone, 9-hydroxyrisperidone levels, CYP2D6 and ABCB1 variants",
        "CYP2D6 worldwide genetic variation shows high frequency of altered activity variants and no continental structure",
        "Impact of pharmacogenetic markers of CYP2D6 and DRD2 on prolactin response in risperidone-treated thai children and adolescents with autism spectrum disorders",
        "Impact of CYP2D6 polymorphisms on tamoxifen responses of women with breast cancer: A microarray-based study in Thailand",
        "Interindividual variability in cytochrome P450-mediated drug metabolism",
        "Prolactin release in children treated with risperidone: Impact and role of CYP2D6 metabolism",
        "Detection of CYP2D6 polymorphism using Luminex xTAG technology in autism spectrum disorder: CYP2D6 activity score and its association with risperidone levels",
        "Different enantioselective 9-hydroxylation of risperidone by the two human CYP2D6 and CYP3A4 enzymes",
        "Polymorphism of human cytochrome P450 2D6 and its clinical significance: Part II"
    ],
    "affiliation": [
        {
            "affiliation-city": "Bangkok",
            "@id": "60020543",
            "affilname": "Bumrungrad International Hospital",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60020543",
            "affiliation-country": "Thailand"
        },
        {
            "affiliation-city": "Bangkok",
            "@id": "60199578",
            "affilname": "Ramathibodi Hospital",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60199578",
            "affiliation-country": "Thailand"
        },
        {
            "affiliation-city": "Bangkok",
            "@id": "60028190",
            "affilname": "Chulalongkorn University",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60028190",
            "affiliation-country": "Thailand"
        },
        {
            "affiliation-city": "Bangkok",
            "@id": "60015887",
            "affilname": "Faculty of Medicine Ramathibodi Hospital, Mahidol University",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60015887",
            "affiliation-country": "Thailand"
        },
        {
            "affiliation-city": "Nontaburi",
            "@id": "60015728",
            "affilname": "Thailand Ministry of Public Health",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60015728",
            "affiliation-country": "Thailand"
        },
        {
            "affiliation-city": "Chiangmai",
            "@id": "60006387",
            "affilname": "Payap University",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60006387",
            "affiliation-country": "Thailand"
        },
        {
            "affiliation-city": "Bangkok",
            "@id": "60005800",
            "affilname": "Faculty of Medicine, Srinakharinwirot University",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60005800",
            "affiliation-country": "Thailand"
        }
    ],
    "funding": [
        "Khun Poom Foundation",
        "The Project in Her Royal Highness Princess Ubonratana Rajakanya Siriwatana Bhanawadee",
        "Mahidol University",
        "National Research Council of Thailand"
    ]
}